Pfizer Industry News – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Pfizer Industry News

Inception Point Ai

News

Frequency: 1 episode/2d. Total Eps: 95

Stay informed with "Pfizer Industry News," your go-to source for the latest updates and insights on Pfizer's innovations, pharmaceutical advancements, and industry trends. Join us as we explore breakthrough therapies, corporate developments, and expert interviews, keeping you ahead in the dynamic world of healthcare and medicine.

For more info go to
https://www.quietperiodplease....

Check out these deals https://amzn.to/48MZPjs

https://podcasts.apple.com/us/...

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

🇩🇪 Germany - businessNews
09/10/2025
#78
🇩🇪 Germany - businessNews
08/10/2025
#51
🇨🇦 Canada - businessNews
17/01/2025
#94
🇨🇦 Canada - businessNews
16/01/2025
#66
🇨🇦 Canada - businessNews
15/01/2025
#42

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://amzn.to/3QFpYIX
190 shares
https://amzn.to/48MZPjs
2 shares

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 64%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Pfizer Surges on Strong Q2 Results, Boosted Guidance and Innovation Momentum

Wednesday, August 6, 2025 • Duration 02:57

# Pfizer Surges After Impressive Q2 Results and Raised Guidance: Healthcare Giant's Comeback Story

Discover how pharmaceutical powerhouse Pfizer (PFE) is making a remarkable market comeback following stellar Q2 2024 performance. This episode dives deep into Pfizer's surprising 4% stock rally, trading around $24.75, as the company exceeds Wall Street expectations and significantly raises its full-year profit outlook to $2.90-$3.10 per share. Learn about the key revenue drivers behind Pfizer's impressive 10% year-over-year growth to $14.7 billion, with standout performances from Comirnaty COVID-19 vaccine and Vyndaqel heart medication, the latter seeing global sales surge 21% to $1.6 billion. We analyze Pfizer's strategic expansion through its Three SBio oncology partnership and positive European regulatory reviews for its updated COVID-19 vaccine. Find out why analysts are setting bullish price targets averaging $28.28, with some projecting up to $34, and why Pfizer's attractive 6.8% dividend yield makes it compelling for both value and income investors as the pharmaceutical giant successfully diversifies beyond its COVID portfolio and rebuilds market confidence.

For more http://www.quietplease.ai

Stock up on these deals
https://amzn.to/3QFpYIX

This content was created in partnership and with the help of Artificial Intelligence AI

Read moreCollapse

Pfizer's Post-Pandemic Transition: Balancing Growth and Investor Confidence

Monday, August 4, 2025 • Duration 02:21

# Pfizer Stock Analysis: Post-Pandemic Revival and Strategic Growth Opportunities | Investment Podcast EpisodeExplore Pfizer's financial trajectory in our latest podcast episode, where we analyze the pharmaceutical giant's current market position with a $134 billion market cap. Discover why PFE shares are showing signs of revival despite post-pandemic revenue adjustments, with trading volumes exceeding 51 million shares ahead of a crucial earnings report. We break down how Pfizer's strategic $43 billion Seagen acquisition is transforming its oncology portfolio and why analysts project potential 20% upside with price targets averaging $29.92. For investors seeking dividend income (7%+ yield) and healthcare sector exposure, this episode examines Pfizer's transition strategy, R&D investments, and whether this pharmaceutical stalwart deserves a place in your portfolio as it rebuilds momentum beyond COVID-19 products. Perfect for healthcare investors, dividend seekers, and anyone tracking major pharmaceutical stocks in today's market.For more Stock up on these deals This content was created in partnership and with the help of Artificial Intelligence AI

Pfizer Industry News – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Pfizer Industry News – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Amazon2

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Amazon2

Other2

Apple Podcast2